Strain Name: |
FVB-Tg(KRT14-MAP2K1/Esr1)12Pkha/J |
|---|---|
Stock Number: |
006822 |
Availability: | Repository- Live |
General Terms and Conditions |
| Genes & Alleles | Esr1; KRT14; MAP2K1; Tg(KRT14-MAP2K1/Esr1)12Pkha; |
Type JAX® GEMM® Strain - Coisogenic Additional information on JAX® GEMM® Strains. Type JAX® GEMM® Strain - Mutant Strain Type JAX® GEMM® Strain - Transgenic Mating System Noncarrier x Hemizygote (Female x Male) Species laboratory mouse Donating Investigator Paul Khavari, Stanford University Generation N9+ (15-MAY-07) Strain Description
Mice hemizygous for this "K14-Mek1:ER" transgene are viable and fertile. Following topical application of 4-hydroxytamoxifen (4OHT), increased epidermal expression of the Mek1:ER fusion protein is observed. Induction of this constitutively active form of human Map2k1 (Mek1R4F) promotes the undifferentiated, proliferative phenotypic characteristics (including hyperplasia, increased levels of phosphorylated ERK1/2, increased mitotic index, decreased expression of differentiation markers and increased expression of beta-1 and beta-4 integrin subunits) observed in epidermal neoplasia in as few as 5 days. Mek1R4F-induced skin abnormalities were entirely reversed within ten days after 4OHT administration cessation. These mice have a similar 4OHT-inducible skin phenotype as the transgenic mice expressing human H-RasG12V (Stock No. 006403) or human Raf-1[DD] (Stock No. 006661), and may be useful in studies of the Ras/Raf/MEK/ERK cell proliferation and differentiation pathway, as well as in elucidating cellular events preceding skin cancer cell transformation.Strain Development
The “K14-Mek1:ER” transgene was designed with a 2075-bp human keratin 14 promoter sequence upstream of the constitutively active mutant region from human mitogen activated protein kinase-kinase 1 (Mek1R4F; containing an amino-terminal deletion of aa 32-51 and the S218E/S222D substitutions) fused at its carboxy terminal with the G525R mutant murine estrogen receptor ligand binding domain (ERTM), which renders transgene expression tamoxifen (4OHT) inducible yet estrogen insensitive. This transgene was injected into the pronuclei of FVB embryos and chimeric founders were established. Mice from founder line 12 were then backcrossed to FVB inbred mice for at least 8 generations prior to arrival at The Jackson Laboratory.
Mammalian Phenotype Terms assigned by genotype |
| Allele Symbol | Tg(KRT14-MAP2K1/Esr1)12Pkha | ||
|---|---|---|---|
| Allele Name | transgene insertion 12, Paul A Khavari | ||
| Common Name(s) | CA-Mek1:ER; CA-Mek1:ER (line 12); K14-Mek1:ER (line 12); M1E-12; Mek1:ER; | ||
| Mutation Made By | Paul Khavari, Stanford University | ||
| Strain of Origin | FVB | ||
| Expressed Gene | Esr1, estrogen receptor 1 (alpha), mouse, laboratory | ||
| Expressed Gene | MAP2K1, mitogen-activated protein kinase kinase 1, human | ||
| Promoter | KRT14, keratin 14 (epidermolysis bullosa simplex, Dowling-Meara, Koebner), human | ||
| General Note | Of three PCR-confirmed transgenic mouse lines, two - designated lines 12 and 13 - express the fusion protein in skin. Topical tamoxifen treatment induces similar skin phenotypes in both lines that are more severe in line 12, which was therefore used in further studies. | ||
| Molecular Note | The transgene contains a 2075-bp human keratin 14 promoter construct with a 5' intron from a beta-globin gene driving expression of a cDNA that encodes a constitutively active mutant human mitogen activated protein kinase-kinase 1 (with deletion of aminoacids 32-51, which comprise a putative alpha-helical domain, and the amino acid substitutions Ser218Glu and Ser222Asp, which remove phosphorylatively regulable serines). This is joined at its COOH-terminal with the Gly525Arg mutant ligand binding domain of the mouse estrogen receptor (ERTM), which renders the fusion protein's activity inducible by 4-hydroxytamoxifen, but unresponsive to natural estrogen (17beta-estradiol). [MGI Ref ID J:118584] [MGI Ref ID J:118587] [MGI Ref ID J:118713] [MGI Ref ID J:118714] [MGI Ref ID J:92407] | ||
| Control | ||
|---|---|---|
| Noncarrier | ||
| 001800 FVB/NJ | ||
| Considerations for Choosing Controls | ||
Tg(KRT14-MAP2K1/Esr1)12Pkha
| Breeding & Husbandry | When maintaining a live colony, hemizygotes are bred to wildtype siblings or to inbred FVB/NJ (Stock No. 001800) mice. |
|---|---|
| Diet Information | LabDiet® 5K52/5K67 |
Strains carrying other alleles of Esr1
006403 129S.B6-Tg(KRT14-Esr1/HRAS)1Pkha/J 004744 B6.129P2-Esr1tm1Ksk/J 004682 B6.Cg-Tg(CAG-cre/Esr1)5Amc/J 005657 B6.Cg-Tg(Myh6-cre/Esr1)1Jmk/J 005650 B6129-Tg(Myh6-cre/Esr1)1Jmk/J 006774 FVB-Tg(Col2a1-cre/ESR1)KA3Smac/J 004453 STOCK Tg(CAG-cre/Esr1)5Amc/J 008122 STOCK Tg(Ins2-cre/Esr1)1Dam/J 005107 STOCK Tg(KRT14-cre/Esr1)20Efu/J 008119 STOCK Tg(Neurog3-cre/Esr1)1Dam/J View Strains carrying other alleles of Esr1 (10 strains)
Strains carrying other alleles of KRT14
006403 129S.B6-Tg(KRT14-Esr1/HRAS)1Pkha/J 006661 129S.B6-Tg(KRT14-RAF1/ESR1)1Pkha/J 004853 B6.C3-Tg(KRT14-Birc5)19Gros/J 007622 B6;SJL-Tg(KRT14-Hr)551Cct/J 007678 B6;SJL-Tg(KRT14-rtTA)208Jek/J 002980 C57BL/6-Tg(Cd152Ig)1Jbs/J 005705 FVB-Tg(KRT14-Vegfa)3Dtm/J 008099 FVB-Tg(KRT14-rtTA)F42Efu/J 004782 STOCK Tg(KRT14-cre)1Amc/J 005107 STOCK Tg(KRT14-cre/Esr1)20Efu/J View Strains carrying other alleles of KRT14 (10 strains)
Strains carrying other alleles of MAP2K1
006662 C57BL/6-Tg(ACTB-MAP2K1*K97M)1Stl/J View Strains carrying other alleles of MAP2K1 (1 strain)
Room Number AX11
Cancer Research
Genes Regulating Growth and Proliferation
Other
Cell Biology Research
Genes Regulating Growth and Proliferation
Signal Transduction
Dermatology Research
Other
Research Tools
Cancer Research
Cell Biology Research
Dermatology Research
Selected Reference(s)
Additional ReferencesScholl FA; Dumesic PA; Khavari PA. 2004. Mek1 alters epidermal growth and differentiation. Cancer Res 64(17):6035-40. [PubMed: 15342384] [MGI Ref ID J:92407]
| Strain Name: | FVB-Tg(KRT14-MAP2K1/Esr1)12Pkha/J |
| Stock Number: | 006822 |
IMPORTANT NOTE: Prices are based on shipping destination. To view prices, select your shipping destination.
| Standard Supply | Repository-Live. A collection of over 1000 strains maintained as live colonies. Individual colonies are sized to meet current customer demand. Delivery for orders of 10 mice or less ranges on average from one to eight weeks; mice are generally shipped between four to six weeks of age with a maximum shipping age of ~nine weeks. Colony sizes do not generally support stringent age specifications for large volumes of mice; however custom orders and larger quantities of mice are easily arranged. Estimated ship dates for all orders provided within 48 hours of order placement. |
|---|---|
| Supply Notes |
Usually shipped between four and eight weeks of age. This strain is included in the Induced Mutant Resource Colony collection. |
| Licensing | See General Terms and Conditions below for Licensing and Use Restrictions |
| Control Information | View Control Information in Strain Details. |
For additional Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form